InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（10 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
10
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Bazemore Todd, 首席运营官. Officer active across 3 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 16 disclosures have been published. Split: 0 buy · 10 sells. Total volume traded: €132k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 22 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bazemore Todd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
47,768 股@ US$0.8337.2% 占其流量Common StockSEC:0001605767-25-000004:0
4,058 股@ US$4.0124.3% 占其流量Common StockSEC:0001415889-25-018319:0
3,390 股@ US$3.7425.5% 占其流量Common StockSEC:0001415889-25-015679:0
10,100 股0Common StockSEC:0001415889-25-001062:0
4,653 股@ US$4.7563.8% 占其流量Common StockSEC:0001415889-24-018377:0
2,093 股@ US$6.0936.2% 占其流量Common StockSEC:0001415889-24-015226:0
6,500 股0Common StockSEC:0001415889-24-000766:0
48,698 股0Common StockSEC:0001415889-23-010283:0
21,158 股Common StockSEC:0001415889-23-009134:0
12,800 股0Common StockSEC:0001415889-23-000637:0
214 股@ US$6.511.8% 占其流量Common StockSEC:0001415889-22-010881:0
3,092 股@ US$0.370.0070% mcap1.4% 占其流量Common StockSEC:0001415889-22-007060:0
3,454 股@ US$1.309.9% 占其流量Common StockSEC:0001415889-22-000403:0
12,544 股@ US$1.8048.7% 占其流量Common StockSEC:0001415889-21-005011:0
2,911 股@ US$5.7735.2% 占其流量Common StockSEC:0001415889-21-003257:0
13,750 股Common StockSEC:0000908662-16-000427:0
16 条申报中的 16 条
About Bazemore Todd
Bazemore Todd is Chief Operating Officer. He has 16 filings in total, and the 16 sampled filings, from 2016-01-22 to 2025-10-24, show only sales for a total of EUR 131745, with filings at KALA BIO, Inc. and Kala Pharmaceuticals, Inc.
